Skip to main content
All lobbying filings

SHIONOGI INC.

Lobbying for SHIONOGI INC. · Pharmaceutical company

 Filing · LD-1 registration Registration amendment
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Nov 25, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey

Official filing document

 Lobbying activity 7
Budget/Appropriations

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

Health Issues

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

Medical/Disease Research/Clinical Labs

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

Insurance

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

Medicare/Medicaid

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

Pharmacy

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

Science/Technology

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 and S. 2076)

 Bills named in this filing 2
 Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

  • SHIONOGI & COMPANY, LIMITED
    Japan · Osaka · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem